Laura Cornish, NP
Adult Health · Federal Way, WANPI 1649637497
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,657 of the $5,538 with a category attached, or 84.1%. It is spread thinly across 46 manufacturers, the largest accounting for just 8.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $5,110 and has fallen 94.6% since, to $278 in 2023. Among adult health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $24.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$444
- Lilly USA, LLC$367
- AstraZeneca$367
- E.r. Squibb & Sons, L.L.C.$338
- Seagen Inc.$284
- Novartis$268
- plus $3K from 40 others
What the payments were for
- Food & beverage$4,65784%
- Education$88116%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,538 in reported general payments places this provider in the 95th percentile of 252 adult health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $110,209 |
| EliquisApixaban | 77 | $80,146 |
| OzempicSemaglutide | 41 | $67,520 |
| RybelsusSemaglutide | 43 | $49,187 |
| XareltoRivaroxaban | 20 | $24,820 |
| JardianceEmpagliflozin | 12 | $18,116 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $17,146 |
| Famotidine | 105 | $4,987 |
| Duloxetine Hcl | 258 | $3,970 |
| Potassium Chloride | 220 | $3,782 |
| Sucralfate | 15 | $3,568 |
| Gabapentin | 149 | $3,450 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 101 | $3,355 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,688 |
| Metoprolol Succinate | 188 | $2,565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $84 | $110,209114 claims |
| PfizerEliquis | $23 | $80,14677 claims |
| Johnson & JohnsonXarelto | $194 | $24,82020 claims |
| Boehringer IngelheimJardiance | $118 | $18,11612 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $1,229165 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 252 adult health providers in Washington.
Other adult health in Federal Way
- George BaxterSeattle$868K
- April WatkinsSeattle$101K
- Ming Chi HsiaoTacoma$46K
- Leslie SwansonSeattle$18K
- Kindra Clark-SnustadSeattle$10K
- Amanda NortonBellevue$8K
- Alexxia RichmondSnohomish$7K
- Jonathan TurowskiMill Creek$7K
- Tyler ChristensenWalla Walla$6K
- Robert PleyoRichland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.